| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/12/2013 | CA2442594C Vip3 pesticidal toxin from bacillus thuringiensis |
| 02/12/2013 | CA2416988C Leucine-based motif and clostridial neurotoxins |
| 02/12/2013 | CA2365903C Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine |
| 02/12/2013 | CA2359650C Pharmaceutical preparations and methods for inhibiting tumors |
| 02/12/2013 | CA2345817C Novel methods for therapeutic vaccination |
| 02/12/2013 | CA2304350C Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 02/12/2013 | CA2274490C Non-m non-o hiv strains, fragments and applications |
| 02/12/2013 | CA2230144C Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 02/07/2013 | WO2013020101A2 Cell free translation system for compound screening and related uses |
| 02/07/2013 | WO2013020090A2 STREPTOCOCCAL GLcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM |
| 02/07/2013 | WO2013019964A1 Systems and methods to increase protein yield from recombinant manufacturing processes |
| 02/07/2013 | WO2013019805A1 Treatment of heart failure and related conditions |
| 02/07/2013 | WO2013019800A1 Vlps containing ligands and methods related thereto |
| 02/07/2013 | WO2013019681A2 Selective delivery molecules and methods of use |
| 02/07/2013 | WO2013019652A1 Purified proteins |
| 02/07/2013 | WO2013019634A1 Alpha toxin detection of gpi anchored proteins |
| 02/07/2013 | WO2013019604A2 Protein production method |
| 02/07/2013 | WO2013019600A1 Axmi279 pesticidal gene and methods for its use |
| 02/07/2013 | WO2013019098A1 Helicobacter pylori proteins for diagnostic kit and vaccine |
| 02/07/2013 | WO2013018977A1 Edar ligand-derived peptide and uses thereof |
| 02/07/2013 | WO2013018976A1 Wnt family-derived peptide and uses thereof |
| 02/07/2013 | WO2013018886A1 Pharmaceutical composition for treatment and/or prevention of pancreatic cancer |
| 02/07/2013 | WO2013018885A1 Method for detecting pancreatic cancer |
| 02/07/2013 | WO2013018882A1 Fusion gene of kif5b gene and ret gene, and method for determining effectiveness of cancer treatment targeting fusion gene |
| 02/07/2013 | WO2013018880A1 Novel modified protein comprising tandem-type multimer of mutant extracellular domain of protein g |
| 02/07/2013 | WO2013018866A1 Method for assessing myelodysplastic syndrome or myeloid tumor predisposition, polypeptide and antibody therefor, and candidate screening method for therapeutic drug or prophylactic drug therefor |
| 02/07/2013 | WO2013018836A1 Method for inhibiting non-specific binding in step of detecting substance in biological sample, and agent for use in the method |
| 02/07/2013 | WO2013018778A1 Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct |
| 02/07/2013 | WO2013018690A1 Erap1-derived peptide and use thereof |
| 02/07/2013 | WO2013018098A2 Long-acting growth hormone and methods of producing same |
| 02/07/2013 | WO2013018097A2 Novel sequences for the control of reproduction in fish |
| 02/07/2013 | WO2013017954A2 Tetrameric streptavidin mutein with reversible biotin binding capability |
| 02/07/2013 | WO2013017830A1 Leptin receptor structure |
| 02/07/2013 | WO2013017713A1 Hrsv f protein in the stabilised pre-fusion state and specific neutralising antibodies against same |
| 02/07/2013 | WO2013017679A1 Process for preparing human relaxin-2 |
| 02/07/2013 | WO2013017645A1 Mutations in the epidermal growth factor receptor gene |
| 02/07/2013 | WO2013017591A1 Hypoallergenic variants of mal d 1, the major allergen from malus domestica |
| 02/07/2013 | WO2013017570A1 Novel prrs virus inducing type i interferon in susceptible cells |
| 02/07/2013 | WO2013017545A1 Humanized hla-a2 / hla-dp4 transgenic mice and uses thereof as an experimental model for biomedical research and development |
| 02/07/2013 | WO2013017522A1 Alteration of proteolytic cleavage of botulinum neurotoxins |
| 02/07/2013 | WO2013017293A1 Powdery mildew resistance providing genes in cucumis sativus |
| 02/07/2013 | WO2013017272A1 Method for purifying virus-like particles (vlp) |
| 02/07/2013 | WO2013016896A1 Agrocybe aegerita lectin aal-2, and encoding gene thereof, preparation method therefor and application thereof |
| 02/07/2013 | WO2013016810A1 Organelle targeting nanocarriers |
| 02/07/2013 | WO2013016805A1 Recombinant swine influenza virus and uses thereof |
| 02/07/2013 | WO2012154735A3 Thermostable carbonic anhydrases and methods of use thereof |
| 02/07/2013 | US20130036519 Compositions and Methods for the Control of Root Lesion Nematode |
| 02/07/2013 | US20130035474 Collagen mixture and method of making the same |
| 02/07/2013 | US20130035472 Method of producing transcripts using cryptic splice sites |
| 02/07/2013 | US20130035471 Tetrameric Streptavidin Mutein With Reversible Biotin Binding Capability |
| 02/07/2013 | US20130035469 Antimicrobial Peptides and Methods of Use |
| 02/07/2013 | US20130035293 Compositions and methods for modulating dopamine neurotransmission |
| 02/07/2013 | US20130035287 Transient immortalization |
| 02/07/2013 | US20130035286 Pharmaceutical Composition Comprising Cyclic Somatostatin Analogues |
| 02/07/2013 | US20130035285 Novel glucagon analogues |
| 02/07/2013 | US20130035260 Genes involved in inflammatory bowel diseases and use thereof |
| 02/07/2013 | US20130035256 Chimeric Polypeptides Useful in Proximal and Dynamic High-Throughput Screening Methods |
| 02/07/2013 | US20130035249 Methods and compositions for detecting and treating cea-expressing cancers |
| 02/07/2013 | US20130034914 Fluorescence-based approach to monitor release factor-catalyzed termination of protein synthesis |
| 02/07/2013 | US20130034897 Bacterial host cell for the direct expression of peptides |
| 02/07/2013 | US20130034893 Methods for Coupling of Molecules to Metal/Metal Oxide Surfaces |
| 02/07/2013 | US20130034849 Diagnosis of hereditary spastic paraplegias (hsp) by detection of a mutation in the kiaa1840 gene or protein |
| 02/07/2013 | US20130034848 Tumor suppressor gene p33ing2 |
| 02/07/2013 | US20130034580 Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
| 02/07/2013 | US20130034576 Novel adenovirus isolated from titi monkeys |
| 02/07/2013 | US20130034575 Method for identification, isolation and production of antigens to a specific pathogen |
| 02/07/2013 | US20130034561 Isolated mammalian monocyte cell genes; related reagents |
| 02/07/2013 | US20130034560 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
| 02/07/2013 | US20130034557 Cancer-Related Glycopeptide Epitopes, Antibodies And Methods Of Use |
| 02/07/2013 | US20130034556 Free hexasaccharide isolated from several campylobacter species |
| 02/07/2013 | US20130034551 Wnt Antagonists and Methods of Treatment and Screening |
| 02/07/2013 | US20130034547 Reliable stabilization of n-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns |
| 02/07/2013 | CA2848369A1 Fusion gene of kif5b gene and ret gene, and method for determining effectiveness of cancer treatment targeting fusion gene |
| 02/07/2013 | CA2844355A1 Axmi279 pesticidal gene and methods for its use |
| 02/07/2013 | CA2844147A1 Methods for measuring hdl subpopulations |
| 02/07/2013 | CA2844037A1 Pharmaceutical composition for treatment and/or prevention of pancreatic cancer |
| 02/07/2013 | CA2844033A1 Method for detecting pancreatic cancer |
| 02/07/2013 | CA2843905A1 Cell free translation system for compound screening and related uses |
| 02/07/2013 | CA2843896A1 Collagen 7 and related methods |
| 02/07/2013 | CA2843804A1 Hypoallergenic variants of mal d 1, the major allergen from malus domestica |
| 02/07/2013 | CA2843672A1 Long-acting growth hormone and methods of producing same |
| 02/07/2013 | CA2843535A1 Treatment of heart failure and related conditions |
| 02/07/2013 | CA2843386A1 Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct |
| 02/07/2013 | CA2843197A1 Purified proteins |
| 02/07/2013 | CA2842872A1 Recombinant swine influenza virus and uses thereof |
| 02/07/2013 | CA2842722A1 Organelle targeting nanocarriers |
| 02/07/2013 | CA2842395A1 Process for preparing human relaxin-2 |
| 02/07/2013 | CA2842368A1 Switch costimulatory receptors |
| 02/07/2013 | CA2842270A1 Mutations in the epidermal growth factor receptor gene |
| 02/07/2013 | CA2841933A1 Alteration of proteolytic cleavage of botulinum neurotoxins |
| 02/07/2013 | CA2841249A1 Selective delivery molecules and methods of use |
| 02/07/2013 | CA2828638A1 Powdery mildew resistance providing genes in cucumis sativus |
| 02/06/2013 | EP2554664A1 Method for purifying virus-like particles |
| 02/06/2013 | EP2554658A1 Method for culturing cells in system containing laminin-5 |
| 02/06/2013 | EP2554551A1 Mutations in the epidermal growth factor receptor gene |
| 02/06/2013 | EP2554550A1 Method for inhibiting hiv replication in mammal and human cells |
| 02/06/2013 | EP2553464A1 Fertilization prediction and promotion |
| 02/06/2013 | EP2553453A1 Tools for the identification of lingo-1, lingo-2, lingo-3 and lingo-4, ligands, and uses thereof |
| 02/06/2013 | EP2553452A1 Detection of feline immunodeficiency virus |
| 02/06/2013 | EP2553111A2 Methods for enhancing by-products from fermentation processes |